Sponsor hub
University of California, Los Angeles clinical trial failures
Review 67 stopped clinical trials from University of California, Los Angeles, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 46
- OTHER/UNKNOWN
- 18
- EFFICACY/FUTILITY
- 3
Notable sponsors
- University of California, Los Angeles
- 67
Related phases
- Phase IV
- 19
- Phase II
- 14
- Phase I
- 12
- Early Phase I
- 9
- Unknown
- 9
Crawlable stopped-trial records
Open ExploreShowing up to 67 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Unknown Growth Failure trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
The sponsor has notified us that they are not funding the study
Early Phase I Cocaine Use Disorder trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Departmental support
Phase II Pulmonary Embolism trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
no sponsor support
Early Phase I Endodontic Disease trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Enrollment difficulties
Unknown Arterial Occlusion trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Initiating PI left our institution.
Phase II PTSD, Post Traumatic Stress Disorder trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Under review with FDA
Phase I Lung Transplant Recipient trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Moderna Bivalent COVID-19 Vaccine became available to the public in Sept 2022.
Phase IV Dyspnea trial by University of California, Los Angeles. Stop reason: EFFICACY/FUTILITY.
Conducted an interim analysis on similar data
Unknown Epilepsy trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
not funded
Unknown Schizophrenia, Treatment-Resistant trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Action of PI. Loss of sponsor
Phase I Dopamine D2/3 Receptor Availability trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Global pandemic
Phase II Hepatorenal Syndrome trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Funding issues; the study was never started
Phase IV Glaucoma Open-Angle Primary trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Problems unique to COVID-19, incomplete data due to a high rate of dropout to minimize non-essential appointments and difficult subject recruitment
Phase IV Schizophrenia trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Withdraw of financial support by industry collaborator
Early Phase I Stimulant Use trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Study never initiated
Early Phase I Depression trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
COVID-19
Phase IV Hypothyroidism trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Sponsor terminated study low accrual numbers
Phase IV Ischemic Stroke trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Funding Discontinued
Early Phase I Dry Eyes Chronic trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Lack of funding/support
Phase IV Surgical Site Infection trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Do not have adequate funding to proceed with project.
Phase II Severe Combined Immunodeficiency Due to ADA Deficiency trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Recruitment on hold for business reasons. Study will not be performed.
Unknown Virtual Reality trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
No patients enrolled
Phase II Brain Injuries, Traumatic trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
The manufacturer of sodium lactate has stopped making the medication
Early Phase I Depression trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
COVID-19
Phase IV Thyroid Eye Disease trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
recruitment challenges
Phase II Stroke trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Poor recruitment for each site, partly related to Covid epidemic.
Phase II Alcohol Use Disorder trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Project was not funded.
Phase I Systemic Lupus Erythematosus Arthritis trial by University of California, Los Angeles. Stop reason: EFFICACY/FUTILITY.
Response rate in placebo group for primary outcome was 100% on interim analysis.
Phase I Laparoscopic Myomectomy trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Closed prior to completion secondary to surgeon leaving UCLA
Phase IV Lung Transplant Rejection trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Rheumatoid Arthritis trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
The study team did not enroll any patients due to difficulty with recruitment.
Phase II Episodic Ataxia Type 2 trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Intracerebral Hemorrhage trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
The funding period for the study has ended.
Phase IV Cardiac Disease trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Poor study design and too many study groups.
Phase III Lung Transplant trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
lack of enrollment
Phase I Methamphetamine Use Disorder trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Deemed unable to enroll targeted participants in part due to COVID-19 shut downs
Phase I Autism Spectrum Disorder trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
COVID
Phase II Cholestasis trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
study intervention was approved by the FDA
Phase II Multiple Sclerosis trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Lack of funding
Early Phase I Enterobacteriaceae Infections trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Investigator left the institution
Phase III Hypercholesterolemia trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Unable to obtain supplement for this study. Unable to recruit.
Phase I Alcohol Use Disorder trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Investigator left institution prior to enrollment of study participants
Phase II Cholesterol Lowering trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
We were unable to procure the supplement for this study.
Early Phase I Cognitive Dysfunction trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Study withdrawn. No participants enrolled.
Phase IV Hepatitis C trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Funding no longer available
Phase IV C.Surgical Procedure trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Study was never initiated.
Phase IV Cigarette Smoking trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Investigator left institution prior to enrollment of study participants
Phase IV Pulmonary Arterial Hypertension trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
inclusion/exclusion criteria limited enrollment
Phase I Crohn's Disease trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Low enrollment
Phase III Parkinson's Disease trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Prevalence of H Pylori in the study population was much lower than anticipated
Unknown Congenital Heart Disease trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
slow enrollment
Phase I Methamphetamine Abuse trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
End in funding
Phase III Analgesic Affect trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
unknown - no record of study conduct in departmental archive
Phase IV Face Pain trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Lack of eligible patients willing and able to participate
Phase I Pro-inflammatory Activity trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Unable to recruit prescription opioid abusers; ultimately no potential POA recruit passed the pre-screening process
Phase IV Emergence Agitation trial by University of California, Los Angeles. Stop reason: EFFICACY/FUTILITY.
Interim analysis revealed a negative effect.
Phase IV Pregnancy trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Poor Enrollment
Phase IV Chronic Obstructive Pulmonary Disease trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Sponsor withdrew funding prior to study initiation
Phase II Multiple Sclerosis trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
NIH did not fund the study so it never started
Phase I Myopic Macular Degeneration trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Study to be revised. Future plans to be determined.
Phase IV Cholestasis trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
The study was terminated due to slow enrollment.
Phase I Substance-Related Disorders trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Unable to recruit adaquate number of GHB dependent subjects
Phase IV Apoptotic DNA Damage trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
The PI has left UCLA and we do not plan to pursue this study.
Early Phase I Crohn's Disease trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
patients insurance would not cover the cost of the study procedures
Unknown Atopic Dermatitis trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
Inadequate funding to support this fellow-in-training initiated study.
Phase II Schizophrenia trial by University of California, Los Angeles. Stop reason: OTHER/UNKNOWN.
Study terminated at Sponsor's request.
Unknown Pulmonary Arterial Hypertension trial by University of California, Los Angeles. Stop reason: OPERATIONAL.
enrollment was too slow